COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDER
双相情感障碍的合作基因组研究
基本信息
- 批准号:6392426
- 负责人:
- 金额:$ 130.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2004-03-14
- 项目状态:已结题
- 来源:
- 关键词:bipolar depression cell line clinical research cooperative study cryopreservation data collection methodology /evaluation disease /disorder etiology family genetics gene expression gene frequency genetic disorder genetic markers genetic registry /resource /referral center genetic susceptibility genotype human genetic material tag human subject interview linkage disequilibriums linkage mapping mental disorder diagnosis polymerase chain reaction
项目摘要
DESCRIPTION: (Adapted from investigator's abstract)
Bipolar affective disorder is a severe heritable condition affecting about
one percent of the population. The mode of inheritance is poorly
understood and probably involves multiple loci of small to moderate
effect. Genetic linkage studies have not been robust although some reports
of linkage have been replicated several times. The NIMH began a national
archival database for search of linked genes in this condition in 1988.
Its purpose was to collect a large sample of interviews and cell line from
families suitable for linkage and association studied. Four centers
participated in the initiative: Indiana University, John Hopkins
University, Washington University of St. Louis, and the NIMH Intramural
Program. A new structured polydiagnostic interview, the Diagnostic
Interview for Genetic Studies (DIGS), was developed and field-tested.
Ascertainment was begun in 1992 to identify Bipolar I (BPI) probands with
a BPI or Schizoaffective, Bipolar type (SA/BP) first degree relative. Two
hundred and forty=three families have been enrolled int he program
including 1025 affected subjects. Twenty one hundred sixty five structured
interviews have been given and 2097 immortalized cells lines have been
cryopreserved. A genomic survey has been completed on 540 subjects
selected from 97 families and eight candidate areas for linkage have been
identified, some supporting previous findings. These cell lines and
related clinical information has been publicly released. A follow-up
sample is presently being genotyped, with particular attention to areas of
interest identified in the original survey.
It is proposed to extend the present study through families identified by
a BPI-BPI sib pair at eight sites (Indiana, Washington University of St.
Louis, Johns Hopkins, University of Pennsylvania, University of
California, San Diego University of Utah, University of Chicago, and
University of Iowa). A total of 450 new families and 2500 cell lines and
interviews over the next four years will be added. This sample will be
used to confirm and extend present findings of linkage, to narrow the
implicated regions, and to test candidate genes. Genotypes will be shared
with a consortium of investigators studying linkage in bipolar illness.
Cell lines and interview data will be made freely available to the
scientific community.
描述:(改编自研究者摘要)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John P. Rice其他文献
The Vicissitudes of Competitive Advantage: Empirical Evidence from Australian Manufacturing SMEs*
竞争优势的变迁:来自澳大利亚中小企业的经验证据*
- DOI:
10.1111/jsbm.12078 - 发表时间:
2015 - 期刊:
- 影响因子:6.2
- 作者:
Tung;John P. Rice;J. Lu - 通讯作者:
J. Lu
A configuration-based approach to integrating dynamic capabilities and market transformation in small and medium-sized enterprises to achieve firm performance
基于配置的方法,整合中小企业的动态能力和市场转型,以实现企业绩效
- DOI:
10.1177/0266242613495035 - 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
John P. Rice;Tung;P. Galvin;Nigel J. Martin - 通讯作者:
Nigel J. Martin
OPENNESS IN PRODUCT AND PROCESS INNOVATION
产品和工艺创新的开放性
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Fang;John P. Rice - 通讯作者:
John P. Rice
Voltage-gated calcium channel activity and complex related genes and schizophrenia: A systematic investigation based on Han Chinese population
电压门控钙通道活性及复杂相关基因与精神分裂症:基于汉族人群的系统调查
- DOI:
10.1016/j.jpsychires.2018.09.020 - 发表时间:
2018 - 期刊:
- 影响因子:4.8
- 作者:
Tianxiao Zhang;Li Zhu;Tong Ni;Dan Liu;Gang Chen;Zhilan Yan;Huali Lin;Fanglin Guan;John P. Rice - 通讯作者:
John P. Rice
Exploring CBD Retail Performance, Recovery and Resilience of a Smart City Following COVID-19
探索 COVID-19 后智慧城市的 CBD 零售绩效、恢复和弹性
- DOI:
10.3390/su15108300 - 发表时间:
2023 - 期刊:
- 影响因子:3.9
- 作者:
P. Fieger;G. Prayag;D. Dyason;John P. Rice;C. M. Hall - 通讯作者:
C. M. Hall
John P. Rice的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John P. Rice', 18)}}的其他基金
Training in the Genetics and Genomics of Mental Disorders
精神疾病遗传学和基因组学培训
- 批准号:
9386891 - 财政年份:2016
- 资助金额:
$ 130.28万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
7183495 - 财政年份:1998
- 资助金额:
$ 130.28万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6873667 - 财政年份:1998
- 资助金额:
$ 130.28万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6720903 - 财政年份:1998
- 资助金额:
$ 130.28万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6989088 - 财政年份:1998
- 资助金额:
$ 130.28万 - 项目类别:
GENETIC LINKAGE STUDIES OF THE AFFECTIVE DISORDER
情感障碍的遗传连锁研究
- 批准号:
2248934 - 财政年份:1994
- 资助金额:
$ 130.28万 - 项目类别:
GENETIC LINKAGE STUDIES OF THE AFFECTIVE DISORDER
情感障碍的遗传连锁研究
- 批准号:
2248932 - 财政年份:1994
- 资助金额:
$ 130.28万 - 项目类别:
GENETIC LINKAGE STUDIES OF THE AFFECTIVE DISORDER
情感障碍的遗传连锁研究
- 批准号:
2248933 - 财政年份:1994
- 资助金额:
$ 130.28万 - 项目类别:
GENETIC LINKAGE STUDIES OF THE AFFECTIVE DISORDER
情感障碍的遗传连锁研究
- 批准号:
2430940 - 财政年份:1994
- 资助金额:
$ 130.28万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 130.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 130.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 130.28万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 130.28万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 130.28万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 130.28万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 130.28万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 130.28万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 130.28万 - 项目类别:
Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 130.28万 - 项目类别:














{{item.name}}会员




